Local Anesthetic Injection Into Both Angles of the Rectus Sheath Incision
Overview
Local anesthetic will be injected into both angles of the rectus sheath incision in an attempt to block sensory nerves in this area that cause the sensation of pain from lscs wound.
Full Title of Study: “Efficacy of Local Anesthetic Injection Into Both Angles of the Rectus Sheath Incision for Postoperative Cesarean Delivery Analgesia.”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Study Primary Completion Date: November 2015
Interventions
- Drug: 10ml of bupivacaine 0.5%
- This is a local anesthetic that will be used to block the ilioinguinal nerve to alleviate pain at the wound site after lscs
- Drug: Placebo
- 10 ml of saline will be injected as a placebo and the investigator and the patient and the data assessor are all blinded to what the patients received.
Arms, Groups and Cohorts
- Experimental: bupivacaine group
- This is the group of patients that will receive 10ml of bupivacaine 0.5% injection in both angles of the rectus sheath incision
- Placebo Comparator: saline group
- This group will receive saline injections as placebo into both angles of the rectus sheath incision
- Experimental: bupivacaine and saline group
- This group will receive saline injection in one angle and 10ml of bupivacaine 0.5% injection in the opposite angle.
Clinical Trial Outcome Measures
Primary Measures
- Pain assessment during rest and ambulation by visual analogue scale
- Time Frame: for 24 hours after lscs
Participating in This Clinical Trial
Inclusion Criteria
- patients booked for lscs – primisection – singleton pregnancy Exclusion Criteria:
- emergency cesarean section – bleeding tendency – hypersensitivity to local anesthetic
Gender Eligibility: Female
Minimum Age: 20 Years
Maximum Age: 40 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Ain Shams Maternity Hospital
- Provider of Information About this Clinical Study
- Principal Investigator: dr mohammed elsafty, Dr Mohammed Elsafty – Ain Shams Maternity Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.